J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

Data Compilation
#PharmaFlow

Pipeline Prospector June 2025: Sanofi, AbbVie, Eli Lilly, BioNTech lead pharma M&A spree; BMS, Astra ink major collaborations

Stock Recap
#PipelineProspector

Nicardipine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

32 API Suppliers, 15 USDMF, 1 CEP/COS, 1 JDMF, 1 EU WC, 2 KDMF, 8 NDC API, 20 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

66 FDF Dossiers, 45 FDA Orange Book, 6 Europe, 1 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML), INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - 40MG/200ML (0.2MG/ML)

RELATED EXCIPIENT COMPANIES

2 Evonik, 1 Rochem International Inc, 6 SPI Pharma, 8 DKSH, 3 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 2 Actylis, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 3 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures, 2 Ingredion Pharma Solutions, 6 Kerry, 3 Lonza Capsugel, 7 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 28 Roquette, 2 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 2 Silverline Chemicals, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

41 Fillers, Diluents & Binders, 28 Coating Systems & Additives, 16 Direct Compression, 15 Thickeners and Stabilizers, 15 Co-Processed Excipients, 14 Controlled & Modified Release, 14 Taste Masking, 13 Film Formers & Plasticizers, 12 Lubricants & Glidants, 11 Granulation, 8 Empty Capsules, 7 Chewable & Orodispersible Aids, 7 Parenteral, 7 Disintegrants & Superdisintegrants, 5 Solubilizers, 4 Emulsifying Agents, 4 Topical, 3 Coloring Agents, 1 Rheology Modifiers, 1 Soft Gelatin, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 19 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 Regulatory FDF Prices

7 Regulatory FDF Prices

MARKET PLACE

18 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

22 US Patents, 2 US Exclusivities, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM

1 EDQM

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
28/06/2025	MSN Laboratories	India	MSN LABORATORIES PRIVATE LIMITED Rudraram Village IN	CEP 2024-005 - Rev 00	Nicardipine hydrochloride	2025-06-04	Valid	Chemical		2776

Nicardipine Hydrochloride

Nicardipine Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

32 API Suppliers

15 USDMF

1 CEP/COS

1 JDMF

1 EU WC

2 KDMF

8 NDC API

20 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

66 FDF Dossiers

45 FDA Orange Book

6 Europe

1 South Africa

14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML)

INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INTRAVENOUS - 40MG/200ML (0.2MG/ML)

RELATED EXCIPIENT COMPANIES

2 Evonik

1 Rochem International Inc

6 SPI Pharma

8 DKSH

3 Faran Shimi Pharmaceutical

4 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

4 ACG Worldwide

2 Actylis

1 Alcedo Pharmachem

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

11 BASF

3 Corel Pharma Chem

2 DFE Pharma

1 Finar

6 Gangwal Chemicals

5 Ideal Cures

2 Ingredion Pharma Solutions

6 Kerry

3 Lonza Capsugel

7 Microlex e.U

2 Nitika Pharmaceutical Specialities

1 Pharmatrans-Sanaq

3 Pluviaendo

2 Prachin Chemical

1 Qualicaps

28 Roquette

2 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

8 Sigachi Industries

2 Silverline Chemicals

2 Valens Pharmachem

2 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

41 Fillers, Diluents & Binders

28 Coating Systems & Additives

16 Direct Compression

15 Thickeners and Stabilizers

15 Co-Processed Excipients

14 Controlled & Modified Release

14 Taste Masking

13 Film Formers & Plasticizers

12 Lubricants & Glidants

11 Granulation

8 Empty Capsules

7 Chewable & Orodispersible Aids

7 Parenteral

INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons